Biogen Idec (BIIB) Tops Q3 EPS by 31c; Boosts FY14 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 252.54 +3.61 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $248.93 | 52 Week High | $333.65 | |||
| Open | $253.54 | 52 Week Low | $223.02 | |||
| Day High | $255.35 | P/E | 32.34 | |||
| Day Low | $252.00 | EPS | $7.81 | |||
| Volume | 87,811 | |||||
